GPGonzalo Piñero

Gonzalo Piñero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gonzalo Piñero has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Alicia Cueto

    Servicio de Neurología, Hospital Español de Buenos Aires, Buenos Aires C1209, Argentina

    2 shared publications
  • Clara Patricia Setton-Avruj

    Facultad de Farmacia y Bioquímica. Departamento de Química Biológica. Cátedra de Química Biológica Patológica Universidad de Buenos Aires Ciudad Autónoma de Buenos Aires Argentina

    2 shared publications
  • Mailin Casadei

    Instituto de Investigaciones en Medicina Traslacional (IIMT), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Austral, Pilar B1629AHJ, Argentina

    2 shared publications
  • Marianela Vence

    Instituto de Química y Fisicoquímica Biológicas (IQUIFIB), Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires C1113AAD, Argentina

    2 shared publications
  • Pablo Rodolfo Brumovsky

    Instituto de Investigaciones en Medicina Traslacional CONICET-Universidad Austral, Buenos Aires, Argentina; Facultad de Ciencias Biomédicas, Universidad Austral, Buenos Aires, Argentina

    2 shared publications
  • Vanina Usach

    Cátedra de Química Biológica Patológica, Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires C1113AAD, Argentina

    2 shared publications

Latest Publications

  • Open Access

    Late Bone Marrow Mononuclear Cell Transplantation in Rats with Sciatic Nerve Crush: Analysis of a Potential Therapeutic Time Window

    by Vanina Usach, Mailin Casadei, Gonzalo Piñero, Marianela Vence, Paula Soto, Alicia Cueto, Pablo Rodolfo Brumovsky, Clara Patricia Setton-Avruj

    After peripheral nerve injury, axon and myelin regeneration are key events for optimal clinical improvements. We have previously shown that early bone marrow mononuclear cell (BMMC) transplantation exerts beneficial effects on myelin regeneration. In the present study, we analyze whether there is a temporal window in which BMMCs migrate more efficiently to damaged nerves while still retaining their positive effects. Adult Wistar rats of both sexes, with sciatic nerve crush, were systemically transplanted with BMMC at different days post injury. Vehicle-treated, naïve, and sham rats were also included. Morphological, functional, and behavioral analyses were performed in nerves from each experimental group at different survival times. BMMC transplantation between 0 and 7 days after injury resulted in the largest number of nested cells within the injured sciatic nerve, which supports the therapeutic value of BMMC administration within the first week after injury. Most importantly, later BMMC administration 7 days after sciatic nerve crush was associated with neuropathic pain reversion, improved morphological appearance of the damaged nerves, and a tendency toward faster recovery in the sciatic functional index and electrophysiological parameters. Our results thus support the notion that even delayed BMMC treatment may represent a promising therapeutic strategy for peripheral nerve injuries.


  • Open Access

    Late Bone Marrow Mononuclear Cell Transplantation in Rats with Sciatic Nerve Crush. Analysis of a Potential Therapeutic Time Window.

    by Vanina Usach, Mailin Casadei, Gonzalo Piñero, Marianela Vence, Paula Soto, Alicia Cueto, Pablo Brumovsky, Clara Patricia Setton-Avruj

    After peripheral nerve injury, axon and myelin regeneration are key events for optimal clinical improvements. We have previously shown that early bone marrow mononuclear cell (BMMC) transplantation exerts beneficial effects on myelin regeneration. In the present study we analyze whether there is a temporal window in which BMMC migrate more efficiently to damaged nerves while still retaining their positive effects. Adult Wistar rats of both sexes, with sciatic nerve crush were systemically transplanted with BMMC at different days post injury. Vehicle-treated, naïve, and sham rats were also included. Morphological, functional, and behavioral analyses were performed in nerves from each experimental group at different survival times. BMMC transplantation between 0 and 7 days after injury resulted in the largest number of nested cells within the injured sciatic nerve, which supports the therapeutic value of BMMC administration within the first week after injury. Most importantly, later BMMC administration 7 days after sciatic nerve crush was associated with neuropathic pain reversion, improved morphological appearance of the damaged nerves, and a tendency toward faster recovery in the sciatic functional index and electrophysiological parameters. Our results thus support the notion that even delayed BMMC treatment may represent a promising therapeutic strategy for peripheral nerve injuries.